{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:44:29Z","timestamp":1773819869496,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12981-016-0128-5","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T14:27:20Z","timestamp":1484317640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Amrei","family":"von Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sekaggya-Wiltshire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra U.","family":"Scherrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Magambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kambugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"128_CR1","unstructured":"WHO. Global Tuberculosis Report. 2014."},{"issue":"9","key":"128_CR2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009\u201321.","journal-title":"Arch Intern Med"},{"issue":"1","key":"128_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/COH.0b013e3283339309","volume":"5","author":"K Cohen","year":"2010","unstructured":"Cohen K, Meintjes G. Management of individuals requiring antiretroviral therapy and TB treatment. Curr Opin HIV AIDS. 2010;5(1):61\u20139.","journal-title":"Curr Opin HIV AIDS."},{"issue":"2","key":"128_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/2049-632X.12108","volume":"70","author":"EM Shankar","year":"2014","unstructured":"Shankar EM, Vignesh R, Ellegard R, Barathan M, Chong YK, Bador MK, et al. HIV-Mycobacterium tuberculosis co-infection: a \u2018danger-couple model\u2019 of disease pathogenesis. Pathog Dis. 2014;70(2):110\u20138.","journal-title":"Pathog Dis."},{"key":"128_CR5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/1471-2458-13-396","volume":"13","author":"P Naidoo","year":"2013","unstructured":"Naidoo P, Peltzer K, Louw J, Matseke G, McHunu G, Tutshana B. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study. BMC Public Health. 2013;13:396.","journal-title":"BMC Public Health."},{"issue":"5","key":"128_CR6","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1097\/QAI.0000000000000820","volume":"70","author":"B Castelnuovo","year":"2015","unstructured":"Castelnuovo B, Nsumba M, Musomba R, Kaimal A, Lwanga I, Kambugu A, et al. Strengthening the \u201cviral failure pathway\u201d: clinical decision and outcomes of patients with confirmed viral failure in a large HIV care clinic in Uganda. J Acquir Immune Defic Syndr. 2015;70(5):e174\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"128_CR7","unstructured":"WHO. Consolidated Guidelines ARV, chapter 7. 2013."},{"issue":"Suppl 2","key":"128_CR8","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1097\/QAD.0000000000000236","volume":"28","author":"GW Rutherford","year":"2014","unstructured":"Rutherford GW, Anglemyer A, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, et al. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. AIDS. 2014;28(Suppl 2):S161\u20139.","journal-title":"AIDS."},{"key":"128_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijid.2014.12.030","volume":"32","author":"LC Bell","year":"2015","unstructured":"Bell LC, Breen R, Miller RF, Noursadeghi M, Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis. 2015;32:39\u201345.","journal-title":"Int J Infect Dis."},{"key":"128_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2015.04.008","volume":"35","author":"AE Ezeamama","year":"2015","unstructured":"Ezeamama AE, Mupere E, Oloya J, Martinez L, Kakaire R, Yin X, et al. Age, sex, and nutritional status modify the CD4\u00a0+\u00a0T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy. Int J Infect Dis. 2015;35:73\u20139.","journal-title":"Int J Infect Dis."},{"issue":"11","key":"128_CR11","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0000000000000685","volume":"29","author":"RK Gupta","year":"2015","unstructured":"Gupta RK, Brown AE, Zenner D, Rice B, Yin Z, Thomas HL, et al. CD4\u00a0+\u00a0cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection. AIDS. 2015;29(11):1363\u20138.","journal-title":"AIDS."},{"issue":"16","key":"128_CR12","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"DV Havlir","year":"2011","unstructured":"Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365(16):1482\u201391.","journal-title":"N Engl J Med"},{"issue":"2","key":"128_CR13","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/QAI.0b013e318251aeb4","volume":"60","author":"SM Hermans","year":"2012","unstructured":"Hermans SM, Castelnuovo B, Katabira C, Mbidde P, Lange JM, Hoepelman AI, et al. Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda. J Acquir Immune Defic Syndr. 2012;60(2):e29\u201335.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"128_CR14","unstructured":"WHO. Guidelines for treatment of tuberculosis. 4th ed. 2010."},{"issue":"11","key":"128_CR15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/aid.2009.0110","volume":"25","author":"L Rajesh","year":"2009","unstructured":"Rajesh L, Karunaianantham R, Narayanan PR, Swaminathan S. Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients. AIDS Res Hum Retroviruses. 2009;25(11):1179\u201385.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"128_CR16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1471-2334-13-482","volume":"13","author":"S Sinha","year":"2013","unstructured":"Sinha S, Raghunandan P, Chandrashekhar R, Sharma SK, Kumar S, Dhooria S, et al. Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study. BMC Infect Dis. 2013;13:482.","journal-title":"BMC Infect Dis"},{"key":"128_CR17","volume-title":"High rates of multi class drug resistance in HIV-1 infected individuals monitored with CD4 count in Uganda","author":"A Braun von","year":"2016","unstructured":"von Braun A, Scherrer AU, Sekaggya C, Kirangwa J, Ssemwanga D, Kaleebu P, G\u00fcnthard H, Kambugu A, Castelnuovo B, Fehr J. High rates of multi class drug resistance in HIV-1 infected individuals monitored with CD4 count in Uganda. HIV Glasgow: Abstract; 2016."},{"issue":"5","key":"128_CR18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/jac\/dkp334","volume":"64","author":"F Maggiolo","year":"2009","unstructured":"Maggiolo F. Efavirenz: a decade of clinical experience in the treatment of HIV. J Antimicrob Chemother. 2009;64(5):910\u201328.","journal-title":"J Antimicrob Chemother"},{"issue":"18","key":"128_CR19","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2165\/00003495-200666180-00003","volume":"66","author":"RA Breen","year":"2006","unstructured":"Breen RA, Swaden L, Ballinger J, Lipman MC. Tuberculosis and HIV co-infection: a practical therapeutic approach. Drugs. 2006;66(18):2299\u2013308.","journal-title":"Drugs."},{"issue":"3","key":"128_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2013.10.022","volume":"43","author":"W Manosuthi","year":"2014","unstructured":"Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, et al. CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy. Int J Antimicrob Agents. 2014;43(3):292\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"128_CR21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1186\/1471-2458-12-980","volume":"12","author":"DM Barter","year":"2012","unstructured":"Barter DM, Agboola SO, Murray MB, Barnighausen T. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa\u2014a systematic review. BMC Public Health. 2012;12:980.","journal-title":"BMC Public Health."},{"issue":"9","key":"128_CR22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1089\/aid.2014.0043","volume":"30","author":"GQ Lee","year":"2014","unstructured":"Lee GQ, Bangsberg DR, Muzoora C, Boum Y, Oyugi JH, Emenyonu N, et al. Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda. AIDS Res Hum Retroviruses. 2014;30(9):896\u2013906.","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-016-0128-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T08:12:07Z","timestamp":1498378327000},"score":1,"resource":{"primary":{"URL":"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-016-0128-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1186\/s12981-016-0128-5","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"article-number":"1"}}